文献速递乳腺MR

整合深度特征提取与MRI影像组学预测乳腺癌新辅助化疗后生存

Integrating Deep Feature Extraction and MRI Radiomics for Survival Prediction in Breast Cancer After Neoadjuvant Chemotherapy.
PubMed 文献 · Acad Radiol · 2025-11-17

多中心研究纳入216例完成新辅助化疗的乳腺癌患者,整合临床、病理组学、ResNet50深度病理特征与多参数MRI影像组学构建多模态Cox模型。该模型预测5年总生存AUC训练集0.890、验证集0.820,7年总生存AUC训练集0.910、验证集0.870,优于单模态模型。

要点

  • 多模态融合模型预测5年OS的AUC训练集0.890、验证集0.820。
  • 预测7年OS的AUC训练集0.910、验证集0.870,优于单模态模型。
  • CNN深度特征与影像组学融合可提供互补预后信息。

核心结论

  • 整合影像、病理与临床数据的多模态模型,尤其纳入CNN深度特征,可提供互补信息并改善新辅助化疗后乳腺癌患者的生存预测。

研究设计与样本

  • 多中心研究纳入216例完成新辅助化疗的乳腺癌患者,提取临床特征、病理组学特征、经ResNet50获得的深度学习病理特征及多参数MRI影像组学特征,构建多模态Cox模型。

诊断标准与关键数值

  • 5年总生存AUC:训练集0.890,验证集0.820。
  • 7年总生存AUC:训练集0.910,验证集0.870。
  • 校准曲线与决策曲线分析证实模型具有稳健的临床实用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Breast cancer (BC) remains a leading contributor to the global cancer burden among women, with neoadjuvant chemotherapy (NAC) established as the standard of care for early-stage disease. However, substantial interpatient variability in treatment outcomes persists, primarily driven by inherent tumor biological heterogeneity. This underscores an urgent need for more precise prognostic tools to optimize clinical decision-making.

MATERIALS AND METHODS: This multicenter study included 216 BC patients who completed NAC, with no overlap in datasets with previous research. We extracted four-dimensional data: clinical characteristics, pathomics features, deep learning-derived pathological features (via ResNet50), and multiparametric MRI (mpMRI) radiomics. A multimodal Cox model integrating deep feature representations and radiomic variables was constructed to combine these data. Notably, this approach differs from prior studies, which have predominantly focused on single-modality inputs (eg, radiomics or pathomics alone) or short-term endpoints such as pathological complete response (pCR).

RESULTS: The proposed model, leveraging deep feature representations derived from CNNs and radiomic fusion, achieved superior prognostic accuracy in predicting 5-year and 7-year overall survival (OS) compared to both single-modality models and findings from previous research. For 5-year OS, it achieved an area under the receiver operating characteristic curve (AUC) of 0.890 in the training set and 0.820 in the validation set; for 7-year OS, the AUC values were 0.910 (training) and 0.870 (validation), with statistically significant superiority over unidimensional models. Calibration curves and decision curve analyses further confirmed its robust clinical utility.

CONCLUSION: The multimodal integration of imaging, pathology, and clinical data, particularly the inclusion of CNN-derived deep features, provides complementary information that improves survival prediction in NAC-treated BC patients. This represents a meaningful advancement over existing models that rely on single-modality data or focus on short-term outcomes.

RESEARCH REGISTRATION UNIQUE IDENTIFYING NUMBER: The study is registered at https://www.chictr.org.cn and has acquired only Identifier: ChiCTR2500098023.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Yuan Q, Hong Z, Ye R, et al. Integrating Deep Feature Extraction and MRI Radiomics for Survival Prediction in Breast Cancer After Neoadjuvant Chemotherapy. Acad Radiol. 2025. PMID: 41253608. doi:10.1016/j.acra.2025.10.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。